Is ZWTYF or MRK a better dividend investment in 2026?

ZWTYF currently yields 166.67% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: ZWTYF offers higher current income.

What is the dividend yield difference between ZWTYF and MRK?

ZWTYF has a forward dividend yield of 166.67% ($2.00/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 163.91 percentage points.

Home › Compare › ZWTYF vs MRK

ZWTYF vs MRK: Dividend Comparison 2026

ZWTYF yields 166.67% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ZWTYF wins by $43.21M in total portfolio value

INVESTMENT

TIME HORIZON10 years

ZWTYF

● Live price

166.67%

Share price

$1.20

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$43.26M

Annual income

$19,842,506.75

Full ZWTYF calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — ZWTYF vs MRK

📍 ZWTYF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ZWTYF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ZWTYF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ZWTYF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ZWTYF

Annual income on $10K today (after 15% tax)

$14,166.67/yr

After 10yr DRIP, annual income (after tax)

$16,866,130.74/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, ZWTYF beats the other by $16,857,802.33/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ZWTYF + MRK for your $10,000?

ZWTYF: 50%MRK: 50%

100% MRK50/50100% ZWTYF

Portfolio after 10yr

$21.66M

Annual income

$9,926,152.44/yr

Blended yield

45.83%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

ZWTYF

No analyst data

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ZWTYF buys

MRK buys

No recent congressional trades found for ZWTYF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricZWTYFMRK

Forward yield	166.67% ✓	2.76%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	32.7% ✓
Portfolio after 10y	$43.26M	$56.8K ✓
Annual income after 10y	$19,842,506.75 ✓	$9,798.13
Total dividends collected	$40.33M ✓	$28.9K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: ZWTYF vs MRK ($10,000, DRIP)

Year	ZWTYF Portfolio	ZWTYF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$27,367	$16,666.67	$11,206	$366.19	+$16.2K → ZWTYF
2	$71,910	$42,627.21	$12,650	$502.35	+$59.3K → ZWTYF
3	$181,624	$104,680.96	$14,407	$694.19	+$167.2K → ZWTYF
4	$441,437	$247,099.04	$16,585	$967.82	+$424.9K → ZWTYF
5	$1,033,621	$561,283.50	$19,342	$1,363.89	+$1.01M → ZWTYF
6	$2,334,237	$1,228,262.46	$22,913	$1,947.19	+$2.31M → ZWTYF
7	$5,089,968	$2,592,334.36	$27,662	$2,823.89	+$5.06M → ZWTYF
8	$10,729,226	$5,282,960.28	$34,159	$4,173.35	+$10.70M → ZWTYF
9	$21,887,784	$10,407,511.91	$43,337	$6,308.80	+$21.84M → ZWTYF
10	$43,262,435	$19,842,506.75	$56,776	$9,798.13	+$43.21M → ZWTYF

ZWTYF vs MRK: Complete Analysis 2026

ZWTYF — Stock

ZhongDe Waste Technology AG designs, invests in, constructs, operates, and finances power plants in Germany and China. The company operates through three segments: Engineering, Procurement & Construction (EPC) Projects; Built, Operate and Transfer Projects; and Incinerators. It operates energy-from-waste incineration plants that generate electricity from the disposal of solid municipal, medical, and industrial waste. The company also provides EPC contractor services, which include design, procurement, construction, and installation of energy-from-waste and incineration plants. ZhongDe Waste Technology AG was founded in 1996 and is headquartered in Frankfurt am Main, Germany.

Full ZWTYF Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this ZWTYF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ZWTYF vs SCHD ZWTYF vs JEPI ZWTYF vs O ZWTYF vs KO ZWTYF vs MAIN ZWTYF vs JNJ ZWTYF vs ABBV ZWTYF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.